These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 36597179)

  • 1. Doubly robust estimation of the hazard difference for competing risks data.
    Rava D; Xu R
    Stat Med; 2023 Jan; ():. PubMed ID: 36597179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Collaborative double robust targeted maximum likelihood estimation.
    van der Laan MJ; Gruber S
    Int J Biostat; 2010 May; 6(1):Article 17. PubMed ID: 20628637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double Robust Efficient Estimators of Longitudinal Treatment Effects: Comparative Performance in Simulations and a Case Study.
    Tran L; Yiannoutsos C; Wools-Kaloustian K; Siika A; van der Laan M; Petersen M
    Int J Biostat; 2019 Feb; 15(2):. PubMed ID: 30811344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statistical inference for data-adaptive doubly robust estimators with survival outcomes.
    Díaz I
    Stat Med; 2019 Jul; 38(15):2735-2748. PubMed ID: 30950107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Data-Adaptive Bias-Reduced Doubly Robust Estimation.
    Vermeulen K; Vansteelandt S
    Int J Biostat; 2016 May; 12(1):253-82. PubMed ID: 27227724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On the estimation of average treatment effects with right-censored time to event outcome and competing risks.
    Ozenne BMH; Scheike TH; Staerk L; Gerds TA
    Biom J; 2020 May; 62(3):751-763. PubMed ID: 32049385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Doubly robust nonparametric inference on the average treatment effect.
    Benkeser D; Carone M; Laan MJV; Gilbert PB
    Biometrika; 2017 Dec; 104(4):863-880. PubMed ID: 29430041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient Estimation of Semiparametric Transformation Models for the Cumulative Incidence of Competing Risks.
    Mao L; Lin DY
    J R Stat Soc Series B Stat Methodol; 2017 Mar; 79(2):573-587. PubMed ID: 28239261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Handling Missing Data in Instrumental Variable Methods for Causal Inference.
    Kennedy EH; Mauro JA; Daniels MJ; Burns N; Small DS
    Annu Rev Stat Appl; 2019 Mar; 6(1):125-148. PubMed ID: 33834080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Doubly robust estimators for generalizing treatment effects on survival outcomes from randomized controlled trials to a target population.
    Lee D; Yang S; Wang X
    J Causal Inference; 2022; 10(1):415-440. PubMed ID: 37637433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Semiparametric regression analysis of interval-censored competing risks data.
    Mao L; Lin DY; Zeng D
    Biometrics; 2017 Sep; 73(3):857-865. PubMed ID: 28211951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving trial generalizability using observational studies.
    Lee D; Yang S; Dong L; Wang X; Zeng D; Cai J
    Biometrics; 2023 Jun; 79(2):1213-1225. PubMed ID: 34862966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding and diagnosing the potential for bias when using machine learning methods with doubly robust causal estimators.
    Bahamyirou A; Blais L; Forget A; Schnitzer ME
    Stat Methods Med Res; 2019 Jun; 28(6):1637-1650. PubMed ID: 29717941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Doubly robust nonparametric instrumental variable estimators for survival outcomes.
    Lee Y; Kennedy EH; Mitra N
    Biostatistics; 2023 Apr; 24(2):518-537. PubMed ID: 34676400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Doubly robust inference for targeted minimum loss-based estimation in randomized trials with missing outcome data.
    Díaz I; van der Laan MJ
    Stat Med; 2017 Oct; 36(24):3807-3819. PubMed ID: 28744883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On doubly robust estimation in a semiparametric odds ratio model.
    Tchetgen Tchetgen EJ; Robins JM; Rotnitzky A
    Biometrika; 2010 Mar; 97(1):171-180. PubMed ID: 23049119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relative performance of targeted maximum likelihood estimators.
    Porter KE; Gruber S; van der Laan MJ; Sekhon JS
    Int J Biostat; 2011; 7(1):. PubMed ID: 21931570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On doubly robust estimation of the hazard difference.
    Dukes O; Martinussen T; Tchetgen Tchetgen EJ; Vansteelandt S
    Biometrics; 2019 Mar; 75(1):100-109. PubMed ID: 30133696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Machine Learning for Causal Inference: On the Use of Cross-fit Estimators.
    Zivich PN; Breskin A
    Epidemiology; 2021 May; 32(3):393-401. PubMed ID: 33591058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Machine learning outcome regression improves doubly robust estimation of average causal effects.
    Choi BY; Wang CP; Gelfond J
    Pharmacoepidemiol Drug Saf; 2020 Sep; 29(9):1120-1133. PubMed ID: 32716126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.